Effects of a Limited Almond Consumption After a Weight Loss Plan on Weight Maintenance

Effects of a Limited Almond Consumption After a Successful Weight Loss by a Comprehensive Weight Loss Plan on Weight Maintenance in Healthy Obese Female Adults: a Randomised Clinical Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03171948

Enrollment

120

Registered

2017-05-31

Start date

2017-06-10

Completion date

2019-01-17

Last updated

2019-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

almond, weight loss, Weight maintenance, hypoenergetic diet

Brief summary

The purpose of this study is to assess the effects of limited portion of almond consumption after a successful weight loss by a comprehensive weight loss plan (NovinDiet Plan) on weight maintenance in obese female adults.

Interventions

BEHAVIORALAlmond Group

Almond Group (AG) are asked to have a 30 gr. almond every day in their afternoon snack plus following the hypoenergetic diet

BEHAVIORALNut Free group

continue their diet without any nut consumption.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Intervention model description

Almond Group (AG) are asked to have a 30 gr. almond every day in their afternoon snack plus following the hypoenergetic diet Nut Free group (NFG), as control group, who continue their diet without any nut consumption.

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* female * 18-45 years of age. * Body mass index (BMI) between 23-30 kg/ m² who lost at least 10% of her initial weight by the diet plan. * Must be able to have moderate exercise. * Must be interested to keep weight loss.

Exclusion criteria

* No Allergy to nut products * Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next 6 months. * Taking medications that could affect metabolism or change body weight. * Report heart problems, chest pain, and cancer within the last five years. * Smoking * Menopause * Diagnosis of any chronic disease such as fatty liver, cancer, chemo/radio therapy, heart disease, immune compromised conditions, abnormal thyroid hormone level.

Design outcomes

Primary

Measure	Time frame	Description
weight loss	6 Month	kg

Secondary

Measure	Time frame	Description
Fasting blood glucose	6 Month	mmol/l
Fasting insulin level	6 Month	mU/l
HbA1c	6 Month	—
Waist circumference	6 Month	cm
lipid profiles	6 Month	mmol/l
liver function	6 Month	U/l
HOMA-IR	6 Month	percentage (%)

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026